CA1049409A - Preparation a usage local contenant un steroide et de la neomycine - Google Patents

Preparation a usage local contenant un steroide et de la neomycine

Info

Publication number
CA1049409A
CA1049409A CA224,302A CA224302A CA1049409A CA 1049409 A CA1049409 A CA 1049409A CA 224302 A CA224302 A CA 224302A CA 1049409 A CA1049409 A CA 1049409A
Authority
CA
Canada
Prior art keywords
weight
neomycin
steroid
betamethasone
benzoate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA224,302A
Other languages
English (en)
Inventor
Martin L. Eichman
Susan C. Belsole
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of CA1049409A publication Critical patent/CA1049409A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA224,302A 1974-04-11 1975-04-10 Preparation a usage local contenant un steroide et de la neomycine Expired CA1049409A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46025474A 1974-04-11 1974-04-11

Publications (1)

Publication Number Publication Date
CA1049409A true CA1049409A (fr) 1979-02-27

Family

ID=23827960

Family Applications (1)

Application Number Title Priority Date Filing Date
CA224,302A Expired CA1049409A (fr) 1974-04-11 1975-04-10 Preparation a usage local contenant un steroide et de la neomycine

Country Status (7)

Country Link
JP (1) JPS535729B2 (fr)
AU (1) AU7776275A (fr)
CA (1) CA1049409A (fr)
DE (2) DE2504615C3 (fr)
DK (1) DK143537C (fr)
FR (1) FR2267107B1 (fr)
GB (1) GB1455552A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984000111A1 (fr) * 1982-06-24 1984-01-19 Robert Alan Smith Composition de gel pharmaceutique

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
AU592065B2 (en) * 1984-10-09 1990-01-04 Dow Chemical Company, The Sustained release dosage form based on highly plasticized cellulose ether gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
ES2078256T3 (es) * 1990-04-05 1995-12-16 Knoll Ag Formula farmaceutica para uso topico que contiene diclofenaco sodico.
AU2000268609A1 (en) * 2000-09-14 2002-03-26 Robert Theiler Intraarticular agent for the treatment of osteoarthritis
EP2366408B1 (fr) * 2010-03-01 2012-07-18 Laboratorios SALVAT, S.A. Solutions claires aqueuses d'acétonide de fluocinolone pour le traitement de l'inflammation otique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1017746B (de) * 1954-02-09 1957-10-17 Upjohn Co Verfahren zur Herstellung frei fliessender, nicht absetzender therapeutisch wirksamer Suspensionen
US3485915A (en) * 1966-04-22 1969-12-23 Revlon Thickened hydroxypropyl cellulose compositions
FR2038105A1 (fr) * 1969-04-01 1971-01-08 Syntex Corp Composition anti-inflammatoire locale et son mode d'utilisation
DK135267A (fr) * 1971-02-25

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984000111A1 (fr) * 1982-06-24 1984-01-19 Robert Alan Smith Composition de gel pharmaceutique

Also Published As

Publication number Publication date
DK143537C (da) 1982-02-01
FR2267107A1 (fr) 1975-11-07
GB1455552A (en) 1976-11-17
JPS50132122A (fr) 1975-10-20
DE2515594A1 (de) 1975-10-30
DE2504615A1 (de) 1975-10-16
DK147575A (fr) 1975-10-12
DK143537B (da) 1981-09-07
DE2504615B2 (de) 1977-07-14
DE2515594C3 (de) 1982-06-03
AU7776275A (en) 1976-08-05
FR2267107B1 (fr) 1978-07-28
DE2504615C3 (de) 1980-10-02
JPS535729B2 (fr) 1978-03-01
DE2515594B2 (de) 1978-12-07

Similar Documents

Publication Publication Date Title
US8232304B2 (en) Antifungal formulations
US5110809A (en) Antifungal gel formulations
EP0362270B2 (fr) Lotion pour application de steroides
US5002938A (en) Antifungal gel formulations
US5414011A (en) Preservative system for ophthalmic formulations
US4323558A (en) Topical trien containing pharmaceutical compositions and methods of use
US4607038A (en) Ophthalmic pranoprofen compositions
EP2420223B1 (fr) Compositions pharmaceutiques aqueuses contenant des complexes de borate-polyol
RU2370265C1 (ru) Гель, обладающий противовоспалительным и противоаллергическим действием
US8546362B2 (en) Medicinal cream made using neomycin sulphate, betamethasone valerate, and chitosan, and a process to make the same
US4873265A (en) Anti-infective methods and compositions
US4013792A (en) Process for the production of base for topical steroids
CA1049409A (fr) Preparation a usage local contenant un steroide et de la neomycine
EP0988040B1 (fr) Utilisation de glucosamine et de derives de glucosamine pour le soulagement rapide de prurit ou de douleurs localisees
US4929619A (en) Anti-infective methods and compositions
JPH08231405A (ja) 局所的眼科用途の為のトブラマイシンとステロイドの組合わせ
RU2398587C2 (ru) Композиция
CA2053721A1 (fr) Composition de creme analgesique antiphlogistique
US4897404A (en) Anti-infective methods and compositions
NZ235054A (en) Gel formulation comprising imidazole antifungal agent and a 17-ester steroid anti-inflammatory agent with a co-solvent system and a gelling agent
US5879711A (en) Stable antiandrogenic gel composition
US4895857A (en) Anti-infective methods and compositions
US4895859A (en) Anti-infective methods and compositions
WO2003097070A1 (fr) Composition pharmaceutique comportant un corticosteroide et un antiseptique
RU2223097C1 (ru) Комбинированное средство для лечения кожных заболеваний